Home › Cancro dell'endometrio › Florida
Studi clinici su Cancro dell'endometrio nello stato di Florida
65 studi su Cancro dell'endometrio cercano partecipanti presso sedi nello stato di Florida.
Città nello stato di Florida
- Orlando17 studi
- Miami16 studi
- Tampa15 studi
- Sarasota15 studi
- Jacksonville13 studi
- West Palm Beach8 studi
- Miami Beach8 studi
- Cape Coral7 studi
- St. Petersburg6 studi
- Gainesville4 studi
- Plantation3 studi
Testo ufficiale dello studio (inglese)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- UM Sylvester Comprehensive Cancer Center at Aventura, Aventura
- UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
- e altri 6
In reclutamentoFase 2
Tutte le età · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05564377The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
- Advent Health, Orlando
- Florida Cancer Specialists South, Port Charlotte
In reclutamentoFase 1/2
Età 12 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT04585750Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
- Sarasota Memorial Hospital-Venice, N. Venice
- Florida Cancer Specialists - Sarasota Downtown, Sarasota
- FPG - Surgical Oncology Clinics Gynecologic Oncology Surgery, Sarasota
- e altri 3
In reclutamentoFase 3
Età 18 e oltre · Donne · Aggiornato il 2 ott 2026 · NCT07198074A Phase 1 Study of the Safety and Tolerability of CTX-10726
- Mayo Clinic Florida, Jacksonville
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT07419841A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus, Fort Myers
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06760819A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- AdventHealth Cancer Institute, Orlando
In reclutamentoFase 1
Età 19 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06586957A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- AdventHealth Medical Group Oncology Research at Celebration, Kissimmee
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06172478The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Mayo Clinic in Florida, Jacksonville
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07285044Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
- Mayo Clinic, Jacksonville
- Genoma Research, Inc., Miami
- Orlando Health, Orlando
- e altri 1
In reclutamentoStudio osservazionale
Età 18 e oltre · Donne · Aggiornato il 29 set 2026 · NCT05051722Study of AVZO-021 in Patients With Advanced Solid Tumors
- Avenzo Therapeutics Recruiting Site, Sarasota
- Avenzo Therapeutics Recruiting Site, Tampa
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT05867251DESTINY-PANTUMOUR04
- Research Site, Coral Springs
- Research Site, St. Petersburg
- Research Site, West Palm Beach
In reclutamentoStudio osservazionale
Età da 18 a 130 · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07124000Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
- Research Site, Jacksonville
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06218914Pembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial Cancer After Progression on or Following First-Line Immunotherapy Maintenance
- University of Miami, Miami
In reclutamentoFase 2
Età 18 e oltre · Donne · Aggiornato il 24 set 2026 · NCT07594015Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
- UM Sylvester Comprehensive Cancer Center at, Deerfield Beach
- UM Sylvester Comprehensive Cancer Center at Doral, Doral
- University of Florida, Gainesville
- e altri 9
In reclutamentoFase 2
Età 18 e oltre · Donne · Aggiornato il 24 set 2026 · NCT05640999Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Florida Cancer Specialists, Sarasota
- Moffitt Cancer Center and Research Institute, Tampa
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT06128551A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Moffitt, Tampa
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07114601EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- Omnicure Clinical Research, Doral
- Bioresearch Partner, Hialeah
- Florida Clinical Trials Group, Plantation
- e altri 1
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07262619Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Sylvester Comprehensive Cancer Center, Miami
- Sara Cannon Research Institute Lake Nona, Orlando
- Hematology - Oncology Associates of the Treasure Coast, Port Saint Lucie
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 21 set 2026 · NCT05983432A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Florida Cancer Specialists - South ( Site 7003), Fort Myers
- UF Health Davis Cancer Pavilion and Shands Med Plaza ( Site 6026), Gainesville
- Mount Sinai Braman Comprehensive Cancer Center ( Site 6031), Miami Beach
- e altri 3
In reclutamentoFase 3
Età 18 e oltre · Donne · Aggiornato il 17 set 2026 · NCT06952504A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- Florida Cancer Specialists - Lake Nona, Orlando
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 set 2026 · NCT07109726A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
- Broward Health Medical Center, Fort Lauderdale
In reclutamentoFase 3
Età 18 e oltre · Donne · Aggiornato il 17 set 2026 · NCT06340568ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Memorial Healthcare System, Hollywood
- The Oncology Institute of Hope & Innovation, Lakeland
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 14 set 2026 · NCT05059444Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- University of Miami, Miami
- Sarah Cannon Research Institute - Lake Nona Florida, Orlando
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 10 set 2026 · NCT06293898Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
- SMH - Sarasota - Main Campus, Sarasota
- Women's Care - 9th Ave, St. Petersburg
- Women's Care - Armenia Ave, Tampa
In reclutamentoFase 3
Età 18 e oltre · Donne · Aggiornato il 9 set 2026 · NCT07166094Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
- Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
In reclutamentoFase 1
Età 18 e oltre · Donne · Aggiornato il 3 set 2026 · NCT07755436DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Research Site, Fort Myers
- Research Site, Miami
- Research Site, Miami Beach
- e altri 4
In reclutamentoFase 3
Età 18 e oltre · Donne · Aggiornato il 3 set 2026 · NCT06989112A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
- Florida Cancer Specialists, Orlando
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 27 ago 2026 · NCT07186842Endometrial Cancer Vaginal Fluid Specimen Collection Study
- Physical Care Clinical Research, Sarasota
In reclutamentoStudio osservazionale
Età 18 e oltre · Donne · Aggiornato il 27 ago 2026 · NCT07544680A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
- SCRI FCS Sarasota, Sarasota
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 27 ago 2026 · NCT07227168A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
- H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., Tampa
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 26 ago 2026 · NCT07383506Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
- Moffitt Cancer Center, Tampa
In reclutamentoFase 1
Età 15 e oltre · Tutti i sessi · Aggiornato il 25 ago 2026 · NCT06276491A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
- Mount Sinai Comprehensive Cancer Center, Miami Beach
In reclutamentoFase 2
Età 18 e oltre · Donne · Aggiornato il 21 ago 2026 · NCT05548296Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
- Mayo Clinic in Florida, Jacksonville
In reclutamentoFase 1/2
Età 16 e oltre · Tutti i sessi · Aggiornato il 20 ago 2026 · NCT05269381A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
- SCRI - Florida Cancer Specialists, Sarasota
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 18 ago 2026 · NCT07470853FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Mayo Clinic, Jacksonville
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 ago 2026 · NCT05919264A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- AdventHealth Celebration, Celebration
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 11 ago 2026 · NCT05592626Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
- Miami Cancer Institute Baptist Health South Florida, Miami
- ADVENTHEALTH (Data collection only), Orlando
In reclutamentoStudio osservazionale
Età 18 e oltre · Donne · Aggiornato il 7 ago 2026 · NCT04291612Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- USOR Florida Cancer Specialists South, Fort Myers
- USOR Florida Cancer Specialists North, St. Petersburg
- USOR Florida Cancer Specialists East, West Palm Beach
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 4 ago 2026 · NCT05579366Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma
- University of Miami, Miami
In reclutamentoFase 1
Età 18 e oltre · Donne · Aggiornato il 3 ago 2026 · NCT05603910A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Florida Cancer Specialists, Fort Myers
- Mayo Clinic (Florida), Jacksonville
- Cancer Specialists of North Florida, Jacksonville
- e altri 2
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 lug 2026 · NCT04657068Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.